Hangzhou Yuhong Pharmaceutical Technology Co., Ltd. announced that it will receive CNY 80,000,000 in an equity round of funding on December 26, 2023. The transaction will include participation from new investors new investors Zhejiang Xianju Pharmaceutical Co.,Ltd. for CNY 40,000,000, Jiaxing Miyin Yuhong Equity Investment Partnership Enterprise (L.P.) for CNY 20,000,000, Hainan Huishengde Enterprise Management Partnership Enterprise (L.P.) for CNY 14,500,000 and Hangzhou Yulin Enterprise Management Partnership Enterprise (L.P.) for CNY 5,500,000. The transaction was approved by the board of directors of Zhejiang Xianju Pharmaceutical Co.,Ltd at its sixth meeting of the company?s eighth board of director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.31 CNY | +0.53% | -3.50% | -11.43% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.43% | 1.54B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- 002332 Stock
- News Zhejiang Xianju Pharmaceutical Co.,Ltd.
- Hangzhou Yuhong Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 80 million in funding from Zhejiang Xianju Pharmaceutical Co.,Ltd., Jiaxing Miyin Yuhong Equity Investment Partnership Enterprise (L.P.), Hainan Huishengde Enterprise Management Partnership Enterprise (L.P.), Hangzhou Yulin Enterprise Management Partnership Enterprise (L.P.)